End-use condition in exemption law: multiple-use hydrazine hydrate stayed subject to drug-intermediate use under the earlier notification.

An exemption for hydrazine hydrate under Notification No. 234/82-C.E. was treated as conditional on actual use as a drug-intermediate where the product had multiple industrial and pharmaceutical uses. Because the goods were capable of use in agriculture, textiles, photography, anti-oxidants, propellants and dyes, the notification was read as carrying an implicit end-use requirement, and the claim failed since pharmacopoeia grade status was not shown. A later notification granting unconditional exemption was held to operate prospectively only and could not control the earlier notification or alter its interpretation. The earlier exemption was therefore unavailable on the stated facts.

---

---

Issues: (i) Whether the benefit of Notification No. 234/82-C.E. could be made subject to an end-use condition where the goods had multiple uses and were claimed as a drug-intermediate. (ii) Whether a subsequent notification granting unconditional exemption to Hydrazine Hydrate could control the interpretation or application of the earlier notification.

Issue (i): Whether the benefit of Notification No. 234/82-C.E. could be made subject to an end-use condition where the goods had multiple uses and were claimed as a drug-intermediate.

Analysis: The goods were found to be capable of multiple uses beyond use as a drug-intermediate, including industrial applications in agriculture, textiles, photography, anti-oxidants, propellants and dyes. In such a situation, the exemption was confined to use as a drug-intermediate, and the requirement of actual end use was treated as implicit in the notification. The goods were also not shown to be pharmacopoeia grade, which distinguished the matter from cases where unconditional exemption had been accepted.

Conclusion: The end-use condition was validly applied and the assessee's challenge failed.

Issue (ii): Whether a subsequent notification granting unconditional exemption to Hydrazine Hydrate could control the interpretation or application of the earlier notification.

Analysis: The later notification was held to operate prospectively from its publication and could not govern the earlier exemption notification. The later exemption only showed a policy change and did not displace the earlier position that, for a product with multiple uses, end use as a drug-intermediate remained material under the earlier notification.

Conclusion: The subsequent notification did not assist the assessee in relation to the earlier period.

Final Conclusion: The exemption under the earlier notification was not available unconditionally in the facts of the case, and the appeal failed.

Ratio Decidendi: Where exempt goods have multiple uses, an exemption confined to use as a drug-intermediate carries an implicit end-use requirement, and a later unconditional exemption does not affect the interpretation of the earlier notification.

---